3717-88-2,MFCD00072099
Catalog No.:AA007AD6

3717-88-2 | Flavoxate Hydrochloride

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
98%
in stock  
$7.00   $5.00
- +
250mg
98%
in stock  
$15.00   $11.00
- +
1g
98%
in stock  
$36.00   $25.00
- +
5g
98%(HPLC)
in stock  
$118.00   $83.00
- +
25g
98%(HPLC)
in stock  
$305.00   $214.00
- +
100g
98%(HPLC)
in stock  
$1,021.00   $715.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA007AD6
Chemical Name:
Flavoxate Hydrochloride
CAS Number:
3717-88-2
Molecular Formula:
C24H26ClNO4
Molecular Weight:
427.9205
MDL Number:
MFCD00072099
SMILES:
O=C(c1cccc2c1oc(c1ccccc1)c(c2=O)C)OCCN1CCCCC1.Cl
NSC Number:
114649
Properties
Computed Properties
 
Complexity:
631  
Covalently-Bonded Unit Count:
2  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
30  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0  
Rotatable Bond Count:
6  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  

Literature

Title: An overview on mixed action drugs for the treatment of overactive bladder and detrusor overactivity.

Journal: Urologia internationalis 20120101

Title: Erythema and hand edema due to flavoxate.

Journal: Journal of investigational allergology & clinical immunology 20120101

Title: Molecularly imprinted polymer for selective extraction of 3-methylflavone-8-carboxylic acid from human urine followed by its determination using zwitterionic hydrophilic interaction liquid chromatography.

Journal: Journal of separation science 20111101

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters 20101101

Title: Lipophilic cationic drugs increase the permeability of lysosomal membranes in a cell culture system.

Journal: Journal of cellular physiology 20100701

Title: Acute myocardial infarction and Kounis syndrome.

Journal: International journal of cardiology 20090515

Title: Liquid chromatographic fingerprint of 3-methylflavone-8-carboxylic acid established for its synthesis control analysis.

Journal: Talanta 20090315

Title: Clinical guidelines for overactive bladder.

Journal: International journal of urology : official journal of the Japanese Urological Association 20090201

Title: High-performance liquid chromatographic determination of flavoxate hydrochloride and its hydrolysis product.

Journal: Drug development and industrial pharmacy 20081201

Title: Bilateral acute angle closure glaucoma in a 50 year old female after oral administration of flavoxate.

Journal: British journal of clinical pharmacology 20081101

Title: [Clinical evaluation of supplemental administration of flavoxate hydrochloride in benign prostatic hyperplasia patients with nocturia resistant to an alpha1-adrenoceptor blocker].

Journal: Hinyokika kiyo. Acta urologica Japonica 20080301

Title: Polymeric matrix membrane sensors for stability-indicating potentiometric determination of oxybutynin hydrochloride and flavoxate hydrochloride urogenital system drugs.

Journal: Journal of AOAC International 20080101

Title: Effects of flavoxate hydrochloride on voltage-dependent Ba2+ currents in human detrusor myocytes at different experimental temperatures.

Journal: Naunyn-Schmiedeberg's archives of pharmacology 20071101

Title: Anticholinergic drugs versus other medications for overactive bladder syndrome in adults.

Journal: The Cochrane database of systematic reviews 20071017

Title: Urodynamic evaluation in primary enuresis: an investigative and treatment outcome correlation.

Journal: Journal of tropical pediatrics 20070801

Title: Anticholinergic drugs versus other medications for overactive bladder syndrome in adults.

Journal: The Cochrane database of systematic reviews 20070718

Title: Drug-induced acute cholestatic liver damage in a patient with mutation of UGT1A1.

Journal: Nature clinical practice. Gastroenterology & hepatology 20070701

Title: High performance liquid chromatographic determination of 3-methylflavone-8-carboxylic acid, the main active metabolite of flavoxate hydrochloride in human urine.

Journal: Journal of pharmaceutical and biomedical analysis 20070509

Title: Conformational evaluation and detailed 1H and 13C NMR assignments of flavoxate, a urinary tract antispasmodic agent.

Journal: Journal of pharmaceutical and biomedical analysis 20060503

Title: The effects of flavoxate hydrochloride on voltage-dependent L-type Ca2+ currents in human urinary bladder.

Journal: British journal of pharmacology 20050901

Title: Activation of the rostral pontine reticular formation increases the spinal glycine level and inhibits bladder contraction in rats.

Journal: The Journal of urology 20050501

Title: Persistence and adherence of medications for chronic overactive bladder/urinary incontinence in the california medicaid program.

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20050101

Title: [Alpha-blockers and bioflavonoids in men with chronic nonbacterial prostatitis (NIH-IIIa): a prospective, placebo-controlled trial].

Journal: Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi 20040201

Title: Incorrect assumption regarding the mechanism of action of flavoxate.

Journal: Journal of the American Geriatrics Society 20020201

Title: Development of a high-performance liquid chromatographic method for bioequivalence study of flavoxate tablets.

Journal: Journal of chromatography. B, Biomedical sciences and applications 20010210

Title: Association between oxybutynin and neuropsychiatric adverse effects not confirmed in daily practice.

Journal: Journal of the American Geriatrics Society 20010201

Title: Rociverine citrate: a new spasmolytic agent, potentially useful in the treatment of urinary bladder hyperreflexia.

Journal: Japanese journal of pharmacology 19861001

Title: Dansette, P.M., et al. HMG-CoA reductase activity in human liver microsomes: comparative inhibition by statins. Exp Toxicol Pathol, 2000. 52(2): p. 145-8.

Title: Kimura, Y., et al., Mechanisms of the suppression of the bladder activity by flavoxate. Int J Urol, 1996. 3(3): p. 218-27.

Title: Oka, M., et al., Brain pertussis toxin-sensitive G proteins are involved in the flavoxate hydrochloride-induced suppression of the micturition reflex in rats. Brain Res, 1996. 727(1-2): p. 91-8.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 3717-88-2
Tags:3717-88-2 Molecular Formula|3717-88-2 MDL|3717-88-2 SMILES|3717-88-2 Flavoxate Hydrochloride
Catalog No.: AA007AD6
3717-88-2,MFCD00072099
3717-88-2 | Flavoxate Hydrochloride
Pack Size: 1mg
Purity: 98%
in stock
$7.00 $5.00
Pack Size: 250mg
Purity: 98%
in stock
$15.00 $11.00
Pack Size: 1g
Purity: 98%
in stock
$36.00 $25.00
Pack Size: 5g
Purity: 98%(HPLC)
in stock
$118.00 $83.00
Pack Size: 25g
Purity: 98%(HPLC)
in stock
$305.00 $214.00
Pack Size: 100g
Purity: 98%(HPLC)
in stock
$1,021.00 $715.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA007AD6
Chemical Name: Flavoxate Hydrochloride
CAS Number: 3717-88-2
Molecular Formula: C24H26ClNO4
Molecular Weight: 427.9205
MDL Number: MFCD00072099
SMILES: O=C(c1cccc2c1oc(c1ccccc1)c(c2=O)C)OCCN1CCCCC1.Cl
NSC Number: 114649
Properties
Complexity: 631  
Covalently-Bonded Unit Count: 2  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 30  
Hydrogen Bond Acceptor Count: 5  
Hydrogen Bond Donor Count: 1  
Isotope Atom Count: 0  
Rotatable Bond Count: 6  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
Literature fold

Title: An overview on mixed action drugs for the treatment of overactive bladder and detrusor overactivity.

Journal: Urologia internationalis20120101

Title: Erythema and hand edema due to flavoxate.

Journal: Journal of investigational allergology & clinical immunology20120101

Title: Molecularly imprinted polymer for selective extraction of 3-methylflavone-8-carboxylic acid from human urine followed by its determination using zwitterionic hydrophilic interaction liquid chromatography.

Journal: Journal of separation science20111101

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters20101101

Title: Lipophilic cationic drugs increase the permeability of lysosomal membranes in a cell culture system.

Journal: Journal of cellular physiology20100701

Title: Acute myocardial infarction and Kounis syndrome.

Journal: International journal of cardiology20090515

Title: Liquid chromatographic fingerprint of 3-methylflavone-8-carboxylic acid established for its synthesis control analysis.

Journal: Talanta20090315

Title: Clinical guidelines for overactive bladder.

Journal: International journal of urology : official journal of the Japanese Urological Association20090201

Title: High-performance liquid chromatographic determination of flavoxate hydrochloride and its hydrolysis product.

Journal: Drug development and industrial pharmacy20081201

Title: Bilateral acute angle closure glaucoma in a 50 year old female after oral administration of flavoxate.

Journal: British journal of clinical pharmacology20081101

Title: [Clinical evaluation of supplemental administration of flavoxate hydrochloride in benign prostatic hyperplasia patients with nocturia resistant to an alpha1-adrenoceptor blocker].

Journal: Hinyokika kiyo. Acta urologica Japonica20080301

Title: Polymeric matrix membrane sensors for stability-indicating potentiometric determination of oxybutynin hydrochloride and flavoxate hydrochloride urogenital system drugs.

Journal: Journal of AOAC International20080101

Title: Effects of flavoxate hydrochloride on voltage-dependent Ba2+ currents in human detrusor myocytes at different experimental temperatures.

Journal: Naunyn-Schmiedeberg's archives of pharmacology20071101

Title: Anticholinergic drugs versus other medications for overactive bladder syndrome in adults.

Journal: The Cochrane database of systematic reviews20071017

Title: Urodynamic evaluation in primary enuresis: an investigative and treatment outcome correlation.

Journal: Journal of tropical pediatrics20070801

Title: Anticholinergic drugs versus other medications for overactive bladder syndrome in adults.

Journal: The Cochrane database of systematic reviews20070718

Title: Drug-induced acute cholestatic liver damage in a patient with mutation of UGT1A1.

Journal: Nature clinical practice. Gastroenterology & hepatology20070701

Title: High performance liquid chromatographic determination of 3-methylflavone-8-carboxylic acid, the main active metabolite of flavoxate hydrochloride in human urine.

Journal: Journal of pharmaceutical and biomedical analysis20070509

Title: Conformational evaluation and detailed 1H and 13C NMR assignments of flavoxate, a urinary tract antispasmodic agent.

Journal: Journal of pharmaceutical and biomedical analysis20060503

Title: The effects of flavoxate hydrochloride on voltage-dependent L-type Ca2+ currents in human urinary bladder.

Journal: British journal of pharmacology20050901

Title: Activation of the rostral pontine reticular formation increases the spinal glycine level and inhibits bladder contraction in rats.

Journal: The Journal of urology20050501

Title: Persistence and adherence of medications for chronic overactive bladder/urinary incontinence in the california medicaid program.

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research20050101

Title: [Alpha-blockers and bioflavonoids in men with chronic nonbacterial prostatitis (NIH-IIIa): a prospective, placebo-controlled trial].

Journal: Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi20040201

Title: Incorrect assumption regarding the mechanism of action of flavoxate.

Journal: Journal of the American Geriatrics Society20020201

Title: Development of a high-performance liquid chromatographic method for bioequivalence study of flavoxate tablets.

Journal: Journal of chromatography. B, Biomedical sciences and applications20010210

Title: Association between oxybutynin and neuropsychiatric adverse effects not confirmed in daily practice.

Journal: Journal of the American Geriatrics Society20010201

Title: Rociverine citrate: a new spasmolytic agent, potentially useful in the treatment of urinary bladder hyperreflexia.

Journal: Japanese journal of pharmacology19861001

Title: Dansette, P.M., et al. HMG-CoA reductase activity in human liver microsomes: comparative inhibition by statins. Exp Toxicol Pathol, 2000. 52(2): p. 145-8.

Title: Kimura, Y., et al., Mechanisms of the suppression of the bladder activity by flavoxate. Int J Urol, 1996. 3(3): p. 218-27.

Title: Oka, M., et al., Brain pertussis toxin-sensitive G proteins are involved in the flavoxate hydrochloride-induced suppression of the micturition reflex in rats. Brain Res, 1996. 727(1-2): p. 91-8.

Building Blocks More >
16499-52-8
16499-52-8
2-Nitro-5-(trifluoromethyl)benzonitrile
AA007AZF | MFCD09264505
109060-64-2
109060-64-2
5-(3-Methylphenyl)-1,3,4-oxadiazol-2-amine
AA007BFX | MFCD00469195
108664-99-9
108664-99-9
16-Oxokahweol
AA007C12 | MFCD00214109
36001-88-4
36001-88-4
Amiprofos methyl
AA007CMB | MFCD00467096
359436-55-8
359436-55-8
Isoguanosine Hydrate
AA007D6D | MFCD01863406
352700-55-1
352700-55-1
(5E)-5-(5-Chloro-2-methoxybenzylidene)-2-mercapto-1,3-thiazol-4(5h)-one
AA007DUW | MFCD04968969
1074-59-5
1074-59-5
3-(Imidazol-4-yl)propionic acid
AA007EE9 | MFCD00237415
33537-97-2
33537-97-2
6-Chloro-1,2,3,4-tetrahydro-isoquinoline HCl
AA007EVW | MFCD08437638
1057682-05-9
1057682-05-9
(R)-6-(3-Methylpiperazin-1-yl)nicotinonitrile
AA007FDO | MFCD17488802
3437-30-7
3437-30-7
3,3-Dimethylpyrrolidine
AA007FV8 | MFCD09864370
Submit
© 2017 AA BLOCKS, INC. All rights reserved.